205 related articles for article (PubMed ID: 569236)
1. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
Di Chiara G; Morelli M; Porceddu ML; Gessa GL
Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
[No Abstract] [Full Text] [Related]
2. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
[TBL] [Abstract][Full Text] [Related]
3. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.
Herrera-Marschitz M; Ungerstedt U
Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effects and supersensitivity following nigral dopamine receptor stimulation.
Kozlowski MR; Sawyer S; Marshall JF
Nature; 1980 Sep; 287(5777):52-4. PubMed ID: 7412875
[No Abstract] [Full Text] [Related]
5. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
Cools AR; Jaspers R; Kolasiewicz W; Sontag KH; Wolfarth S
Behav Brain Res; 1983 Jan; 7(1):39-49. PubMed ID: 6297521
[No Abstract] [Full Text] [Related]
6. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
Bevan P
Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
[TBL] [Abstract][Full Text] [Related]
7. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
8. [Behavior modifications induced by unilateral administration of picrotoxin into rat substantia nigra].
Boulu R; Lebas M; Ngoma-Yengo P
C R Acad Hebd Seances Acad Sci D; 1977 Dec; 285(16):1549-52. PubMed ID: 417832
[TBL] [Abstract][Full Text] [Related]
9. Effect of intrastriatal administration of cholinergic and GABAergic agonists on apomorphine-induced circling.
Kuruvilla A; Uretsky NJ
Psychopharmacology (Berl); 1984; 84(1):42-7. PubMed ID: 6436889
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
Price MT; Fibiger HC
Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
[No Abstract] [Full Text] [Related]
11. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
Olianas MC; De Montis GM; Mulas G; Tagliamonte A
Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
[No Abstract] [Full Text] [Related]
12. A new central direct dopaminergic stimulant: 1-(Coumaran-5-yl methyl)-4-(2-thiazolyl) piperazine hydrochloride (S 3608).
Poignant JC; Gressier H; Petitjean M; Regnier G; Canevari R
Experientia; 1975 Oct; 31(10):1204-5. PubMed ID: 1243126
[No Abstract] [Full Text] [Related]
13. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
Koltai MZ; György L
Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
[TBL] [Abstract][Full Text] [Related]
14. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol.
Cools AR; Janssen HJ
J Pharm Pharmacol; 1976 Jan; 28(1):70-4. PubMed ID: 6658
[No Abstract] [Full Text] [Related]
15. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
Reavill C; Leigh N; Jenner P; Marsden CD
Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
Scheel-Krüger J
Acta Neurol Scand Suppl; 1986; 107():1-54. PubMed ID: 3014800
[No Abstract] [Full Text] [Related]
17. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
[No Abstract] [Full Text] [Related]
18. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
[No Abstract] [Full Text] [Related]
19. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
